David Merryman Archive — Page 1 of 1

kidney stones
August 12, 2026

Study points to new therapeutic target for chronic kidney disease

Researchers showed that blocking the protein cadherin-11 improved survival and kidney function in three kidney injury models.

By Leigh MacMillan
November 15, 2018

Vanderbilt study suggests way to prevent rare lung disease

Research by Vanderbilt scientists suggests that it may be possible to prevent or even reverse pulmonary arterial hypertension, a rare, progressive disease characterized by narrowing of and high blood pressure in the small arteries of the lungs.

By Bill Snyder
David Merryman, associate professor of biomedical engineering, found that a drug developed for rheumatoid arthritis stops a common binding protein from calcifying heart valves. (Vanderbilt University)
June 12, 2017

Drug developed for arthritis could be first to stop heart valve calcification

The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.

By Vanderbilt Health News
February 23, 2016

Hypertension hiatus

New findings offer a potential strategy for preventing heritable pulmonary arterial hypertension.

By Bill Snyder
February 14, 2013

Cell connections key in valve disease

A protein that connects cells together participates in the calcification that occurs in heart valve disease.

By Leigh MacMillan
December 26, 2012

Preventing hardened heart valves

Blocking a serotonin receptor may provide a novel therapy for heart valve disease.

By Leigh MacMillan